FENC vs NXPI · rev $17.9M vs P/E 29, rev $12.27B
Fennec Pharmaceuticals Inc (FENC) versus NXP Semiconductors NV (NXPI) — a side-by-side from cached financials, not a winner call.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
FENC currently screens at market cap $302.2M. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Not investment advice. Open the FENC and NXPI stock pages for the full models.
Not investment advice.